Fact based stock research
Celltrion Healthcare (KOSDAQ:A091990)

KR7091990002



Research has been discontinued. Contact us if you want research on this stock.



How to read the free ranks

For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. The higher the rank, the better the stock performs than its peers. And, we do this for six investment strategies:
Value - shows how good of a value the stock is. Green is "inexpensive"; red is "expensive".

Growth - shows a company's growth potential. Green is "high growth" expected; red is "tough times ahead".

Safety - relates to the amount of debt a company has. Green is low debt level; red is high debt level.

Combined Financial - this isn't an average of the first three ranks but rather a consolidated view across several financial indicators. Green = good; red = tread carefully.

(NEW) Sentiment - quantifies professional analyst ratings and holdings as well as market pulse. Green = positive sentiment; red = skepticism (Only available to Premium Subscribers).

(NEW) 360° View - the ultimate rating with all financial and non-financial indicators.

Celltrion Healthcare stock research in summary

celltrionhealthcare.com


n/a
n/a

Latest Obermatt Ranks


Log in or sign up to see the new 360° View and Sentiment ranks.

360° Viewnew
Sentiment Ranknew
Value Rank n/a
Growth Rank n/a
Safety Rank n/a
Combined Rank n/a
Country South Korea
Industry Health Care Distributors
Index
Size class Large

. Stock data may be delayed. Log in or sign up to get the most recent research.

Add to Watchlist
See Similar Stocks
Subscribe to updates


Multiple opinions. One number.

Analysts rarely agree on a stock’s future. So, who do you believe? Obermatt translates those collective views into a single Sentiment Rank. That plus the financial ranks give you the ultimate 360° View. Sign up to access them.
Why popular stocks have low ratings

It’s easier said than done. When your stock drops, it’s easy to want to sell it and find a better performer. Think twice, or even three times, before trading. Those fees (especially the hidden ones) can eat up your gains.

Review the performance ranks of the individual metrics that form each investment strategy.

Research History: Celltrion Healthcare

RESEARCH HISTORY 2022 2023 2024 2025
VALUE
VALUE 11
10
n/a
n/a
GROWTH
GROWTH 63
71
n/a
n/a
SAFETY
SAFETY 53
43
n/a
n/a
SENTIMENT
SENTIMENT 60
70
n/a
new
360° VIEW
360° VIEW 33
38
n/a
new

Most recent update of the stock research: . Financial reporting date used for calculating ranks: . Stock research history is based on the Obermatt Method. The higher the rank, the better Celltrion Healthcare is in the corresponding investment strategy.
Upgrade to a Premium Account to access the latest ranks.


Combined financial peformance in Detail

n/a n/a
RESEARCH HISTORY 2022 2023 2024 2025
VALUE
VALUE 11
10
n/a
n/a
GROWTH
GROWTH 63
71
n/a
n/a
SAFETY
SAFETY 53
43
n/a
n/a
COMBINED
COMBINED 39
31
n/a
n/a

Last update of combined financial performance: . Stock analysis on combined financial performance: The higher the rank of Celltrion Healthcare the better the performance.


Value Metrics in Detail

n/a n/a
VALUE METRICS 2022 2023 2024 2025
PRICE VS. REVENUES (P/S)
PRICE VS. REVENUES (P/S) 17
15
n/a
n/a
PRICE VS. PROFITS (P/E)
PRICE VS. PROFITS (P/E) 14
12
n/a
n/a
PRICE VS. CAPITAL (Market-to-Book)
PRICE VS. CAPITAL (Market-to-Book) 11
9
n/a
n/a
DIVIDEND YIELD
DIVIDEND YIELD 19
23
n/a
n/a
CONSOLIDATED RANK: VALUE
CONSOLIDATED RANK: VALUE 11
10
n/a
n/a

Last update of Value Rank: . Stock analysis on value ratios: The higher the rank, the lower the value ratio of Celltrion Healthcare; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

n/a n/a
GROWTH METRICS 2022 2023 2024 2025
REVENUE GROWTH
REVENUE GROWTH 82
92
n/a
n/a
PROFIT GROWTH
PROFIT GROWTH 21
66
n/a
n/a
CAPITAL GROWTH
CAPITAL GROWTH 100
5
n/a
n/a
STOCK RETURNS
STOCK RETURNS 3
65
n/a
n/a
CONSOLIDATED RANK: GROWTH
CONSOLIDATED RANK: GROWTH 63
71
n/a
n/a

Last update of Growth Rank: . Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Celltrion Healthcare.


Safety Metrics in Detail

n/a n/a
SAFETY METRICS 2022 2023 2024 2025
LEVERAGE
LEVERAGE 62
51
n/a
n/a
REFINANCING
REFINANCING 41
41
n/a
n/a
LIQUIDITY
LIQUIDITY 55
53
n/a
n/a
CONSOLIDATED RANK: SAFETY
CONSOLIDATED RANK: SAFETY 53
43
n/a
n/a

Last update of Safety Rank: . Stock analysis on safety metrics: The higher the rank, the lower the leverage of Celltrion Healthcare and the more cash is available to service its debt.


Sentiment Metrics in Detail

SENTIMENT 2022 2023 2024 2025
ANALYST OPINIONS
ANALYST OPINIONS n/a
72
n/a
new
OPINIONS CHANGE
OPINIONS CHANGE 50
40
n/a
new
PRO HOLDINGS
PRO HOLDINGS 24
44
n/a
new
MARKET PULSE
MARKET PULSE 84
80
n/a
new
CONSOLIDATED RANK: SENTIMENT
CONSOLIDATED RANK: SENTIMENT 60
70
n/a
new

Last update of Sentiment Rank: . Stock analysis on sentiment metrics: The higher the rank, the more positive the sentiment for Celltrion Healthcare.
Upgrade to a Premium Account to access the latest ranks.


Add to Watchlist
See Similar Stocks
Subscribe to updates

Free stock analysis by the purely fact based Obermatt Method for Celltrion Healthcare from August 22, 2024.

Obermatt Portfolio Performance
We’re so convinced about our free research, that we buy our stock tips.
See the performance of the Obermatt portfolio.